| Product Code: ETC10738282 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Orphan Drug Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Orphan Drug Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Orphan Drug Market - Industry Life Cycle |
3.4 South Korea Orphan Drug Market - Porter's Five Forces |
3.5 South Korea Orphan Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Orphan Drug Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 South Korea Orphan Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 South Korea Orphan Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Orphan Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases in South Korea |
4.2.2 Government initiatives and support for orphan drug development |
4.2.3 Growing awareness and advocacy for rare diseases among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 High cost of orphan drugs leading to affordability issues |
4.3.2 Limited patient population for each rare disease |
4.3.3 Stringent regulatory requirements for orphan drug approval |
5 South Korea Orphan Drug Market Trends |
6 South Korea Orphan Drug Market, By Types |
6.1 South Korea Orphan Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Orphan Drug Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 South Korea Orphan Drug Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.4 South Korea Orphan Drug Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.1.5 South Korea Orphan Drug Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.6 South Korea Orphan Drug Market Revenues & Volume, By Cell Therapy, 2021 - 2031F |
6.1.7 South Korea Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 South Korea Orphan Drug Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 South Korea Orphan Drug Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 South Korea Orphan Drug Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.2.4 South Korea Orphan Drug Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.2.5 South Korea Orphan Drug Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.2.6 South Korea Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 South Korea Orphan Drug Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 South Korea Orphan Drug Market Revenues & Volume, By Prescription Drugs, 2021 - 2031F |
6.3.3 South Korea Orphan Drug Market Revenues & Volume, By Over-the-Counter, 2021 - 2031F |
6.3.4 South Korea Orphan Drug Market Revenues & Volume, By Specialty Drugs, 2021 - 2031F |
6.3.5 South Korea Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.3.6 South Korea Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 South Korea Orphan Drug Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 South Korea Orphan Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 South Korea Orphan Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 South Korea Orphan Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 South Korea Orphan Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.6 South Korea Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
7 South Korea Orphan Drug Market Import-Export Trade Statistics |
7.1 South Korea Orphan Drug Market Export to Major Countries |
7.2 South Korea Orphan Drug Market Imports from Major Countries |
8 South Korea Orphan Drug Market Key Performance Indicators |
8.1 Number of orphan drug designations granted by regulatory authorities in South Korea |
8.2 Funding allocated by the government for orphan drug research and development |
8.3 Number of clinical trials for orphan drugs conducted in South Korea |
8.4 Patient access to orphan drugs through reimbursement schemes and patient assistance programs |
9 South Korea Orphan Drug Market - Opportunity Assessment |
9.1 South Korea Orphan Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Orphan Drug Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 South Korea Orphan Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 South Korea Orphan Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Orphan Drug Market - Competitive Landscape |
10.1 South Korea Orphan Drug Market Revenue Share, By Companies, 2024 |
10.2 South Korea Orphan Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here